PROGNOSTIC VALUE OF THE DAY-7 TO DAY-1 𝛃-HCG RATIO IN THE TREATMENT OF UNRUPTURED ECTOPIC PREGNANCY WITH SINGLE- DOSE METHOTREXATE AT CAN THO OBSTETRICS AND GYNECOLOGY HOSPITAL IN 2024-2026

Minh Tuan Doan1, , Huu Du Nguyen1, Minh Kha Le1
1 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

 Background: Unruptured ectopic pregnancy is a common obstetric emergency in clinical practice, especially in women of reproductive age. If detected early when the patient is hemodynamically stable, medical treatment with a single dose of Methotrexate is considered an effective conservative method, avoiding surgery and help preserve natural fertility. However, post– treatment monitoring plays a crucial role in assessing response and early detection of treatment failure. Objective: To evaluate the prognostic value of the β-hCG ratio on day 7 versus day 1 in the treatment of unruptured ectopic pregnancy with a single dose of Methotrexate. Materials and methods: A single– cohort study was conducted on 141 patients with ectopic pregnancy treated with a single dose of Methotrexate at Can Tho Obstetrics and Gynecology Hospital from 2024 to 2026. Results: The mean age was 30.96 ± 6.371, the 20–35 age group accounted for 71.6%. Common symptoms included delayed menstruation (61.7%), vaginal bleeding (72.3%), and abdominal pain (70.2%). The highest percentage of β-hCG levels ranged from 1000–3000 mIU/ml (57,4%). The success rate after a single dose of Methotrexate was 61%, the overall success rate was 91.5%. A βhCG reduction of  ≥10.6% from day 1 to day 7 had a positive predictive value of 90.8%, sensitivity of 80,2%, and specificity of 87.3% (p<0.001). Conclusion: Single– dose Methotrexate is an effective treatment for unruptured ectopic pregnancy. A decrease in β-hCG of ≥10,6% between day 1 and day 7 is a reliable prognostic factor and can be used in monitoring and predicting treatment outcomes.  

Article Details

References

1. Panelli D. M., Phillips C. H., Brady P. C. Incidence, diagnosis and management of tubal and nontubal ectopic pregnancies: A review. Fertility Research and Practice. 2015. 1, 15, https://doi.org/10.1186/s40738-015-0008-z.
2. Bixby S., Tello R., Kuligowska E. Presence of a yolk sac on transvaginal sonography is the most reliable predictor of single-dose methotrexate treatment failure in ectopic pregnancy. Journal of Ultrasound in Medicine. 2005. 24(5), 591–598, https://doi.org/10.7863/jum.2005.24.5.591.
3. Kirk E., Condous G., Van Calster B., Haider Z., Van Huffel S., Timmerman D., Bourne T. A validation of the most commonly used protocol to predict the success of single-dose methotrexate in the treatment of ectopic pregnancy. Human Reproduction. 2007. 22(3), 858– 863, https://doi.org/10.1093/humrep/del433.
4. Oron G., Tulandi T. A pragmatic and evidence-based management of ectopic pregnancy. Journal of Minimally Invasive Gynecology. 2013. 20(4), 446–454, https://doi.org/10.1016/j.jmig.2013.02.004.
5. Atkinson M., Gupta S., McGee T. β-hCG monitoring after single-dose methotrexate treatment of tubal ectopic pregnancy: Is the Day 4 β-hCG necessary? A retrospective cohort study. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2014. 54(5), 475–479, https://doi.org/10.1111/ajo.12257.
6. Oliveira F. C., Jr, Surita F. G., Pinto E Silva J. L., et al. Severe maternal morbidity and maternal near miss in the extremes of reproductive age: results from a national cross- sectional multicenter study. BMC pregnancy and childbirth. 2014. 14, 77, https://doi.org/10.1186/14712393-14-77.
7. Trương Thị Linh Giang. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng trong các trường hợp thai ngoài tử cung chỉ định điều trị nội khoa. Tạp chí Y Dược Huế. 2024. 7(14), 219–225, https://doi.org/10.34071/jmp.2024.7.31.
8. Vũ Văn Du. Một số đặc điểm lâm sàng, cận lâm sàng và phương pháp phẫu thuật xử trí chửa ngoài tử cung sau thụ tinh trong ống nghiệm. Tạp chí Nghiên cứu Y học. 2022. 160(12V2), 172–179, https://doi.org/10.52852/tcncyh.v160i12V2.1226.
9. Nguyễn Văn Hiền. Đánh giá giá trị chẩn đoán chửa ngoài tử cung của phương pháp siêu âm đường âm đạo tại Bệnh viện Phụ sản Thái Bình năm 2024. Tạp chí Y Dược Thái Bình. 2025. 1(15), 53–59, https://doi.org/10.62685/tbjmp.2025.15.08.
10. Hồ Thị Thu Hằng, Nguyễn Lư Hoàng Phong. Tình hình điều trị nội khoa thai ngoài tử cung chưa vỡ bằng methotrexate đơn liều tại Bệnh viện Đa khoa Vĩnh Long năm 2022–2023. Tạp chí Y học Việt Nam. 2024. 545(1), 315–319, https://doi.org/10.51298/vmj.v545i1.12181
11. Nguyễn Thị Tươi, Nguyễn Hữu Dự. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và đánh giá kết quả điều trị thai ngoài tử cung chưa vỡ bằng methotrexate tại Bệnh viện Phụ sản Thành phố Cần Thơ năm 2019–2020. Tạp chí Y Dược học Cần Thơ. 2023. 40, 230–236, https://tapchi.ctump.edu.vn/index.php/ctump/article/view/826.
12. Piróg M. M., Pulka A., Urbaniec P., Jach R. Comparison of single- and double-dose methotrexate protocols for treatment of pregnancy of unknown location. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2024. 298, 171–174, https://doi.org/10.1016/j.ejogrb.2024.05.016.
13. Nguyễn Văn Thắng, Nguyễn Minh Hoàng, Trần Thị An. Kết quả điều trị nội khoa chửa ngoài tử cung tại Bệnh viện Phụ sản Hà Nội. Tạp chí Y học Việt Nam. 2026. 557(3), https://doi.org/10.51298/vmj.v557i3.16767.
14. Mackenzie S. C., Moakes C. A., Doust A. M., Mol B. W., Duncan W. C., Tong S., Horne A. W., Whitaker L. H. Early (Days 1–4) post-treatment serum hCG level changes predict singledose methotrexate treatment success in tubal ectopic pregnancy. Human Reproduction. 2023. 38, 1261–1267, https://doi.org/10.1093/humrep/dead089.
15. Aiob A., Shqara R. A., Mikhail S. M., Sharon A., Odeh M., Lowenstein L. Alternative betahCG follow-up protocols after single-dose methotrexate therapy for ectopic pregnancy: A retrospective cohort study. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2023. 284, 120–124, https://doi.org/10.1016/j.ejogrb.2023.03.024.
16. Orozco E. M., Sánchez-Durán M. A., Bello-Muñoz J. C., Sagalá J., Carreras E., Roura L. C. ßhCG and prediction of therapeutic success in ectopic pregnancies treated with methotrexate: results from a prospective observational study. The Journal of Maternal-Fetal & Neonatal Medicine. 2015. 28(6), 695–699, https://doi.org/10.3109/14767058.2014.928687.